A unified platform for Pharmaceuticals, Nutritional Supplements, and Cosmetics. Deploy an orchestration of autonomous AI agents to validate ideas, structure regulatory dossiers, and build 100% confidence before real-world lab work begins.
Our intelligence network adapts its scientific reasoning context perfectly for your specific regulatory pathway.
Streamlined Reference Listed Drug (RLD) deconstruction, bioequivalence strategies, and full eCTD dossier generation.
Design effective, scientifically-backed vitamin and botanical blends with rapid label compliance and health claim verification.
Architect stunning skincare products, analyzing active ingredients and predicting formulation stability.
We don't just dump data. GenPharmaAI executes a strict, sequential protocol simulating a real-world R&D lab structure.
The system initializes by securing molecular data, evaluating competitor pricing landscapes, checking patent infringement possibilities, and digesting clinical evidence. The AI rapidly builds a fundamental understanding of what exists and what is financially viable.
Depending on the industry, agents identify the RLD or benchmark product, then execute a Quality by Design (QbD) formulation strategy. It plans the master formula, assesses stability risks, and drafts analytical testing methods simultaneously.
Before proceeding, the product is evaluated for toxicological safety, regulatory label compliance, and bioequivalence necessity. Global supplier intelligence identifies where raw materials can be cost-effectively sourced.
Financial viabilities are updated via detailed Cost Modelling. A Competitive Intelligence SWOT is synthesized. Finally, all agent findings are elegantly fused into a master Product Assessment Report (PAR) and automated regulatory Dossiers.
18 distinct AI Agents, specialized and contextually aligned, sharing context with one another.
Scans global databases to profile authorizations and market share.
Frames the regulatory pathway (e.g., FDA 505(j), EMA generics).
Evaluates generic erosion and determines optimal entry pricing.
Performs early-stage Freedom to Operate and landscaping scans.
Extracts primary endpoints, comparators, and trial structures.
Auto-identifies Reference Listed Drugs and benchmark ingredients.
Suggests excipient ratios using Quality by Design principles.
Recommends dissolution parameters, HPLC setups, and validations.
Assesses biowaiver options or drafts BE clinical study outlines.
Predicts degradation profiles and shelf-life recommendations.
Maps API/raw material suppliers globally.
Assesses impurity limits, PDE, and cosmetic dermatological safety.
Estimates COGS (Cost of Goods Sold) based on material pricing.
Drafts SMpC, PI, and mandatory warning summaries.
Suggests primary blister/bottle components against interaction risks.
Distills insights into actionable Strengths & Weaknesses analysis.
Assembles the executive Product Assessment Report (PAR).
Maps collected evidence into structural dossier drafts.
Join GenPharmaAI and experience the future of formulation and product intelligence today.
Create Free Account